GlassScriptPhysician profile
David Charles Lowe
NPI 1770575227
$1,323.76
in general payments reported to CMS, 2019-2025
23 companies · $28.22 in 2025
The $28.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $28.75 · 2021: $260 · 2022: $588 · 2023: $199 · 2024: $83.11 · 2025: $28.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.13 | 2021-2023 | |
| Hologic Sales and Service, LLC | $156.40 | 2021-2022 | |
| Avion Pharmaceuticals | $133.84 | 2019-2022 | |
| Gynesonics, INC. | $96.69 | 2022 | |
| Astellas Pharma US INC | $71.16 | 2019-2025 | Veozah |
| Evofem Biosciences, INC. | $70.27 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $41.21 | 2021 | |
| Biogen, INC. | $40.99 | 2024 | Zurzuvae |
| Merck Sharp & Dohme LLC | $37.92 | 2019-2022 | |
| Allergan, INC. | $29.02 | 2019 | |
| Lilly USA, LLC | $28.90 | 2024 | Zepbound |
| Renovia INC | $18.32 | 2021 | |
| Currax Pharmaceuticals LLC | $14.73 | 2019 | |
| Sanofi Pasteur INC. | $14.19 | 2025 | |
| Ethicon US, LLC | $13.86 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $13.38 | 2021 | |
| Eisai INC. | $12.95 | 2021 | |
| Mallinckrodt Enterprises LLC | $12.62 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.53 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.91 | 2022 | |
| Vertical Pharmaceuticals, LLC | $11.89 | 2019 | |
| Pfizer INC. | $11.14 | 2021 | |
| Meditrina | $8.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.